Skip to main content
Clinical Trials/NCT00873249
NCT00873249
Completed
N/A

Effect of Daily SMS Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia

AstraZeneca1 site in 1 country339 target enrollmentApril 2009
ConditionsSchizophrenia

Overview

Phase
N/A
Intervention
Not specified
Conditions
Schizophrenia
Sponsor
AstraZeneca
Enrollment
339
Locations
1
Primary Endpoint
Morisky Green Questionnaire
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

This study is a 6-month, multicenter, randomized study to assess the effect of daily SMS reminders sent during 3 months in the adherence to oral antipsychotic treatment in stabilized outpatients with schizophrenia.

Registry
clinicaltrials.gov
Start Date
April 2009
End Date
March 2010
Last Updated
16 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Male or female patients older than 18 years
  • With a diagnosis of schizophrenia (DSM-IV TR criteria)
  • Stabilized out-patients
  • Under oral antipsychotic monotherapy

Exclusion Criteria

  • Administration of a depot antipsychotic drug
  • Suicide risk

Outcomes

Primary Outcomes

Morisky Green Questionnaire

Time Frame: baseline, at months 3 and 6

Secondary Outcomes

  • Clinical Global Impression- Schizophrenia (CGI-SCH)(baseline, at months 3 and 6)
  • Register of Adherence to Treatment (RAT)(baseline, at months 3 and 6)

Study Sites (1)

Loading locations...

Similar Trials